Zealand Pharma A/S (Denmark)'s ticker is and the CUSIP is 999999999. A total of 3 filers reported holding Zealand Pharma A/S (Denmark) in Q3 2013. The put-call ratio across all filers is - and the average weighting 2.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $56,907,000 | -1.2% | 134,268,164 | +5.9% | 7.76% | +6.3% |
| Q2 2014 | $57,621,000 | -22.7% | 126,824,020 | -16.1% | 7.30% | -11.5% |
| Q1 2014 | $74,497,000 | -11.7% | 151,209,346 | -6.2% | 8.25% | -8.7% |
| Q4 2013 | $84,356,000 | +44.6% | 161,282,633 | +18.8% | 9.04% | +26.2% |
| Q3 2013 | $58,342,000 | +42.6% | 135,703,328 | -5.2% | 7.16% | +29.8% |
| Q2 2013 | $40,916,000 | – | 143,142,401 | – | 5.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MARXE AUSTIN W & GREENHOUSE DAVID M | 135,703,328 | $58,342,000 | 7.16% |
| Hirtle Callaghan & Co LLC | 2 | $75,000 | 0.01% |
| NORDEA INVESTMENT MANAGEMENT AB | 182,824 | $0 | 0.00% |